Recommended Reading: My Voice, My Choice

Twin Cities MN Senior Care Advice Book Recommended Reading
My Voice, My Choice A Practical Guide to Writing a Meaningful Healthcare Directive by Anne Elizabeth Denny This book is written by a local resident of the Twin Cities who’s worked within the health care industry for 16 years and also journeyed with her mother through Alzheimer’s for twenty years. My Voice, My Choice explains […]
Continue reading →

Depression in Older Adults & the Elderly

Senior Health Education Tips Difference Between Depression or Dementia Twin Cities MN
May is Mental Health Month Recognize the Signs and Find Treatment that Works The changes that often come in later life – retirement, the death of loved ones, increased isolation, medical problems—can lead to depression. Depression prevents you from enjoying life like you used to. But its effects go far beyond mood. It also impacts your […]
Continue reading →

Recommended Reading

Recommended Reading Through the Wilderness of Alzheimer’s Twin Cities MN
Through the Wilderness of Alzheimer’s By: Robert Simpson, Anne Simpson Nearly four million Americans have Alzheimer’s disease, a debilitating neurological disorder affecting the memory that places great stress on the sufferer as well as the caregivers. Robert and Anne Simpson share the story of Bob’s early onset of Alzheimer’s in order to give families accurate, […]
Continue reading →

Senior Housing General Tips

Senior Housing General Tips From the “Questions to Ask” series at www.SeniorsE-Guide.com Deciding where to live as one ages, presents new challenges for many seniors. Anticipating and planning for this stage of life is difficult because how well we will age and how long we will live is unpredictable. Average life expectancy is lengthening, increasing the potential […]
Continue reading →

Parkinson’s Drug in Pipeline

Parkinson's Disease Information Seniors Twin Cities MN
New Report on Parkinson’s Drug in Pipeline A new report released by Pharmaceutical Research and Manufacturers of America (PhRMA) outlines 37 new Parkinson’s disease drugs either in clinical trials or awaiting review by the Food and Drug Administration. According to the report, several of the 37 medications are “disease modifying therapies focused on protecting the […]
Continue reading →